brexpiprazole 0.5 MG Oral Tablet

RxCUI: 1658327
RxNorm name: brexpiprazole 0.5 MG Oral Tablet
Display name: brexpiprazole 0.5 MG Oral Tablet
Full name: brexpiprazole 0.5 MG Oral Tablet
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Rexulti	BREXPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	2d301358-6291-4ec1-bd87-37b4ad9bd850	2026-05-06	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1658327
Brexpiprazole	BREXPIPRAZOLE	Ajanta Pharma USA Inc.	993b584c-7fe6-4551-899f-39146c8508ac	2022-12-13	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1658327

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
2d301358-6291-4ec1-bd87-37b4ad9bd850	brexpiprazole 0.5 MG Oral Tablet [PSN] · brexpiprazole 0.5 MG Oral Tablet [SCD]	2	26	These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015	20260506
993b584c-7fe6-4551-899f-39146c8508ac	brexpiprazole 0.5 MG Oral Tablet [PSN] · brexpiprazole 0.5 MG Oral Tablet [SCD]	2	4	These highlights do not include all the information needed to use BREXPIPRAZOLE TABLETS safely and effectively. See full prescribing information for BREXPIPRAZOLE TABLETS. BREXPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2015	20221213